These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

105 related items for PubMed ID: 15753674

  • 1. Volume changes in intra- and extraorbital compartments in patients with Graves' ophthalmopathy: effect of smoking.
    Szucs-Farkas Z, Toth J, Kollar J, Galuska L, Burman KD, Boda J, Leovey A, Varga J, Ujhelyi B, Szabo J, Berta A, Nagy EV.
    Thyroid; 2005 Feb; 15(2):146-51. PubMed ID: 15753674
    [Abstract] [Full Text] [Related]

  • 2. Graves' ophthalmopathy: eye muscle involvement in patients with diplopia.
    Nagy EV, Toth J, Kaldi I, Damjanovich J, Mezosi E, Lenkey A, Toth L, Szabo J, Karanyi Z, Leovey A.
    Eur J Endocrinol; 2000 Jun; 142(6):591-7. PubMed ID: 10832104
    [Abstract] [Full Text] [Related]

  • 3. Using morphologic parameters of extraocular muscles for diagnosis and follow-up of Graves' ophthalmopathy: diameters, areas, or volumes?
    Szucs-Farkas Z, Toth J, Balazs E, Galuska L, Burman KD, Karanyi Z, Leovey A, Nagy EV.
    AJR Am J Roentgenol; 2002 Oct; 179(4):1005-10. PubMed ID: 12239055
    [Abstract] [Full Text] [Related]

  • 4. Significance of orbital fatty tissue for exophthalmos in thyroid-associated ophthalmopathy.
    Nishida Y, Tian S, Isberg B, Hayashi O, Tallstedt L, Lennerstrand G.
    Graefes Arch Clin Exp Ophthalmol; 2002 Jul; 240(7):515-20. PubMed ID: 12136278
    [Abstract] [Full Text] [Related]

  • 5. Graves' ophthalmopathy evolution studied by MRI during childhood and adolescence.
    Antoniazzi F, Zamboni G, Cerini R, Lauriola S, Dall'Agnola A, Tatò L.
    J Pediatr; 2004 Apr; 144(4):527-31. PubMed ID: 15069405
    [Abstract] [Full Text] [Related]

  • 6. [Short-tau inversion-recovery (STIR) sequence magnetic resonance imaging evaluation of orbital structures in Graves' orbitopathy].
    Rodríguez-González N, Pérez-Rico C, López-Para Giménez R, Arévalo-Serrano J, Del Amo García B, Calzada Domingo L, Flores Ruiz L, Blanco R.
    Arch Soc Esp Oftalmol; 2011 Nov; 86(11):351-7. PubMed ID: 22040641
    [Abstract] [Full Text] [Related]

  • 7. The use of real-time orbital ultrasound in Graves' ophthalmopathy: a comparison with computed tomography.
    Given-Wilson R, Pope RM, Michell MJ, Cannon R, McGregor AM.
    Br J Radiol; 1989 Aug; 62(740):705-9. PubMed ID: 2670033
    [Abstract] [Full Text] [Related]

  • 8. Quantitative computed tomography of Graves' ophthalmopathy. Extraocular muscle and orbital fat in development of optic neuropathy.
    Feldon SE, Lee CP, Muramatsu SK, Weiner JM.
    Arch Ophthalmol; 1985 Feb; 103(2):213-5. PubMed ID: 3838463
    [Abstract] [Full Text] [Related]

  • 9. Effect of 131 iodine therapy on the course of Graves' ophthalmopathy: a quantitative analysis of extraocular muscle volumes using orbital magnetic resonance imaging.
    Gupta MK, Perl J, Beham R, Sheeler LR, Foster JA, Gliga M, Mcbride N, Faiman MR, Mehta AE, Dattatreya R, Faiman C.
    Thyroid; 2001 Oct; 11(10):959-65. PubMed ID: 11716044
    [Abstract] [Full Text] [Related]

  • 10. Quantitative evaluation of extraocular muscle with high-field magnetic resonance in patients with Graves' ophthalmopathy with upper-lid retraction.
    Chen Y, Jin ZY, Zhang ZH, Xu DD, Meng W, Jiang B, Fang HY, Sun ZY, Chen Y, Sun HY, Feng F.
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Oct; 34(5):461-7. PubMed ID: 23134821
    [Abstract] [Full Text] [Related]

  • 11. Immunohistochemical staining of normal and Graves' extraocular muscle.
    Tallstedt L, Norberg R.
    Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):175-84. PubMed ID: 2448263
    [Abstract] [Full Text] [Related]

  • 12. The measurement of change in Graves' ophthalmopathy.
    Gorman CA.
    Thyroid; 1998 Jun; 8(6):539-43. PubMed ID: 9669294
    [Abstract] [Full Text] [Related]

  • 13. Graves' ophthalmopathy: V. Aetiology of upper eyelid retraction in Graves' ophthalmopathy.
    Feldon SE, Levin L.
    Br J Ophthalmol; 1990 Aug; 74(8):484-5. PubMed ID: 2390525
    [Abstract] [Full Text] [Related]

  • 14. MR T2 relaxation time for the assessment of retrobulbar inflammation in Graves' ophthalmopathy.
    Utech CI, Khatibnia U, Winter PF, Wulle KG.
    Thyroid; 1995 Jun; 5(3):185-93. PubMed ID: 7580266
    [Abstract] [Full Text] [Related]

  • 15. [Magnetic resonance tomographic differentiation of ocular muscle changes in endocrine orbitopathy].
    Hosten N, Cordes M, Sander B, Schörner W, Wenzel KW, Felix R.
    Rofo; 1990 Apr; 152(4):388-92. PubMed ID: 2160096
    [Abstract] [Full Text] [Related]

  • 16. Immunohistochemical evidence for IgA1 involvement in Graves ophthalmopathy.
    Rosen CE, Raikow RB, Burde RM, Kennerdell JS, Mosseri M, Scalise D.
    Ophthalmology; 1992 Jan; 99(1):146-52. PubMed ID: 1741128
    [Abstract] [Full Text] [Related]

  • 17. Graves' disease of the orbit.
    Weber AL, Dallow RL, Sabates NR.
    Neuroimaging Clin N Am; 1996 Feb; 6(1):61-72. PubMed ID: 8919134
    [Abstract] [Full Text] [Related]

  • 18. [MR relaxation time measurements with and without selective fat suppression (SPIR) in endocrine orbitopathy].
    Pauleit D, Schüller H, Textor J, Leutner C, Keller E, Sommer T, Träber F, Block W, Boldt I, Schild H.
    Rofo; 1997 Dec; 167(6):557-64. PubMed ID: 9465949
    [Abstract] [Full Text] [Related]

  • 19. Orbital tissue-derived T lymphocytes from patients with Graves' ophthalmopathy recognize autologous orbital antigens.
    Otto EA, Ochs K, Hansen C, Wall JR, Kahaly GJ.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3045-50. PubMed ID: 8768872
    [Abstract] [Full Text] [Related]

  • 20. MRI measurements of orbital tissues in dysthyroid ophthalmopathy.
    Nishida Y, Tian S, Isberg B, Tallstedt L, Lennerstrand G.
    Graefes Arch Clin Exp Ophthalmol; 2001 Nov; 239(11):824-31. PubMed ID: 11789862
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.